3,146
Views
77
CrossRef citations to date
0
Altmetric
Reviews

Treatment options for second-stage gambiense human African trypanosomiasis

, , , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Rajan Kumar Pandey, Drista Sharma, Tarun Kumar Bhatt, Shyam Sundar & Vijay Kumar Prajapati. (2015) Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach. Journal of Biomolecular Structure and Dynamics 33:12, pages 2541-2553.
Read now
Philippe Büscher & Stijn Deborggraeve. (2015) How can molecular diagnostics contribute to the elimination of human African trypanosomiasis?. Expert Review of Molecular Diagnostics 15:5, pages 607-615.
Read now

Articles from other publishers (75)

Christian Burri, Pascal Mäser & François Chappuis. 2024. Manson's Tropical Diseases. Manson's Tropical Diseases 623 635 .
Koketso J. Setshedi, Richard M. Beteck, Omobolanle J. Jesumoroti, Kayhan Ilbeigi, Dorien Mabille, Guy Caljon, Frank Van der Kooy & Lesetja J. Legoabe. (2023) 2‐Aroyl quinazolinone: Synthesis and in vitro anti‐parasitic activity. Chemical Biology & Drug Design.
Crossref
Lydia Kisula, Xavier Siwe-Noundou, Tarryn Swart, Heinrich C. Hoppe, Quintino Mgani & Rui WM Krause. (2023) Synthesis, Molecular Docking Analysis and In vitro Evaluation of 1,4- Dihydroxyanthraquinone Derivatives As Anti-Trypanosomal Agents. Letters in Organic Chemistry 20:6, pages 507-518.
Crossref
Mariscal Brice Tchatat Tali, Boniface Pone Kamdem, Jean Claude Tchouankeu & Fabrice Fekam Boyom. (2023) Current developments on the antimalarial, antileishmanial, and antitrypanosomal potential and mechanisms of action of Terminalia spp.. South African Journal of Botany 156, pages 309-333.
Crossref
Albina Waithaka & Christine Clayton. (2022) Clinically relevant benzoxaboroles inhibit mRNA processing in Trypanosoma brucei. BMC Research Notes 15:1.
Crossref
Amrita Sharma, Michael Cipriano, Lori Ferrins, Stephen L. Hajduk & Kojo Mensa-Wilmot. (2022) Hypothesis-generating proteome perturbation to identify NEU-4438 and acoziborole modes of action in the African Trypanosome. iScience 25:11, pages 105302.
Crossref
Nicola S. Carter, Yumena Kawasaki, Surbhi S. Nahata, Samira Elikaee, Sara Rajab, Leena Salam, Mohammed Y. Alabdulal, Kelli K. Broessel, Forogh Foroghi, Alyaa Abbas, Reyhaneh Poormohamadian & Sigrid C. Roberts. (2022) Polyamine Metabolism in Leishmania Parasites: A Promising Therapeutic Target. Medical Sciences 10:2, pages 24.
Crossref
Raquel Inocencio da Luz, Sara Tablado Alonso, Philippe Büscher, Paul Verlé, Anja De Weggheleire, Dieudonné Mumba Ngoyi, Pati Patient Pyana & Epco Hasker. (2022) Two-Year Follow-Up of Trypanosoma brucei gambiense Serology after Successful Treatment of Human African Trypanosomiasis: Results of Four Different Sero-Diagnostic Tests. Diagnostics 12:2, pages 246.
Crossref
Klaudia T. Angula, Lesetja J. Legoabe, Tarryn Swart, Heinrich C. Hoppe & Richard M. Beteck. (2022) Synthesis and in vitro antitrypanosomal evaluation of novel 6-heteroarylidene-substituted quinolone derivatives. European Journal of Medicinal Chemistry 227, pages 113913.
Crossref
Vittoria Lutje, Katrin Probyn, Jorge Seixas, Hanna Bergman & Gemma Villanueva. (2021) Chemotherapy for second-stage human African trypanosomiasis: drugs in use. Cochrane Database of Systematic Reviews 2021:12.
Crossref
Aatreyee M. Das, Nakul Chitnis, Christian Burri, Daniel H. Paris, Swati Patel, Simon E. F. Spencer, Erick M. Miaka & M. Soledad Castaño. (2021) Modelling the impact of fexinidazole use on human African trypanosomiasis (HAT) transmission in the Democratic Republic of the Congo. PLOS Neglected Tropical Diseases 15:11, pages e0009992.
Crossref
Ipos Ngay Lukusa, Nick Van Reet, Dieudonné Mumba Ngoyi, Erick Mwamba Miaka, Justin Masumu, Pati Patient Pyana, Wilfried Mutombo, Digas Ngolo, Vincent Kobo, Felix Akwaso, Médard Ilunga, Lewis Kaninda, Sylvain Mutanda, Dieudonné Mpoyi Muamba, Olaf Valverde Mordt, Antoine Tarral, Sandra Rembry, Philippe Büscher & Veerle Lejon. (2021) Trypanosome SL-RNA detection in blood and cerebrospinal fluid to demonstrate active gambiense human African trypanosomiasis infection. PLOS Neglected Tropical Diseases 15:9, pages e0009739.
Crossref
Ana Lia Mazzeti, Karolina R. Gonçalves, Suianne L. A. Mota, Dário Elias Pereira, Lívia de F. Diniz & Maria Terezinha Bahia. (2021) Combination therapy using nitro compounds improves the efficacy of experimental Chagas disease treatment. Parasitology 148:11, pages 1320-1327.
Crossref
Mohamed A. Abdel-Lateef & Albandary Almahri. (2021) Micellar sensitized Resonance Rayleigh Scattering and spectrofluorometric methods based on isoindole formation for determination of Eflornithine in cream and biological samples. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 258, pages 119806.
Crossref
Minayégninrin Koné, Dramane Kaba, Jacques Kaboré, Lian Francesca Thomas, Laura Cristina Falzon, Mathurin Koffi, Cyrille Mambo Kouamé, Bernardin Ahouty, Charlie Franck Alfred Compaoré, Emmanuel Kouassi N’Gouan, Philippe Solano, Eric Fèvre, Philippe Büscher, Veerle Lejon & Vincent Jamonneau. (2021) Passive surveillance of human African trypanosomiasis in Côte d’Ivoire: Understanding prevalence, clinical symptoms and signs, and diagnostic test characteristics. PLOS Neglected Tropical Diseases 15:8, pages e0009656.
Crossref
Violeta Kourbeli, Eleni Chontzopoulou, Kalliopi Moschovou, Dimitrios Pavlos, Thomas Mavromoustakos & Ioannis P. Papanastasiou. (2021) An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases. Molecules 26:15, pages 4629.
Crossref
Albandary Almahri & Mohamed A. Abdel-Lateef. (2021) Application of Hantzsch reaction for sensitive determination of eflornithine in cream, plasma and urine samples. Royal Society Open Science 8:5.
Crossref
Dorien Mabille, Camila Cardoso Santos, Rik Hendrickx, Mathieu Claes, Peter Takac, Christine Clayton, Sarah Hendrickx, Fabian Hulpia, Louis Maes, Serge Van Calenbergh & Guy Caljon. (2021) 4E Interacting Protein as a Potential Novel Drug Target for Nucleoside Analogues in Trypanosoma brucei. Microorganisms 9:4, pages 826.
Crossref
Erik de Heuvel, Albert J. Kooistra, Ewald Edink, Sjors van Klaveren, Jeffrey Stuijt, Tiffany van der Meer, Payman Sadek, Dorien Mabille, Guy Caljon, Louis Maes, Marco Siderius, Iwan J. P. de Esch, Geert Jan Sterk & Rob Leurs. (2021) Discovery of Diaryl Ether Substituted Tetrahydrophthalazinones as TbrPDEB1 Inhibitors Following Structure-Based Virtual Screening. Frontiers in Chemistry 8.
Crossref
Tetsuya OKADA & Takashi INUI. (2021) Development of therapeutic agents for human African trypanosomiasis. Translational and Regulatory Sciences 3:2, pages 43-50.
Crossref
Giuliana Muraca, Ignacio Rivero Berti, María L. Sbaraglini, Wagner J. Fávaro, Nelson Durán, Guillermo R. Castro & Alan Talevi. (2020) Trypanosomatid-Caused Conditions: State of the Art of Therapeutics and Potential Applications of Lipid-Based Nanocarriers. Frontiers in Chemistry 8.
Crossref
Vasiliki Pardali, Erofili Giannakopoulou, Dimitrios-Ilias Balourdas, Vassilios Myrianthopoulos, Martin C. Taylor, Marina Šekutor, Kata Mlinarić-Majerski, John M. Kelly & Grigoris Zoidis. (2020) Lipophilic Guanylhydrazone Analogues as Promising Trypanocidal Agents: An Extended SAR Study. Current Pharmaceutical Design 26:8, pages 838-866.
Crossref
Christian Burri. (2020) Sleeping Sickness at the Crossroads. Tropical Medicine and Infectious Disease 5:2, pages 57.
Crossref
Andreas K Lindner, Veerle Lejon, François Chappuis, Jorge Seixas, Leon Kazumba, Michael P Barrett, Erick Mwamba, Olema Erphas, Elie A Akl, Gemma Villanueva, Hanna Bergman, Pere Simarro, Augustin Kadima Ebeja, Gerardo Priotto & Jose Ramon Franco. (2020) New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice. The Lancet Infectious Diseases 20:2, pages e38-e46.
Crossref
Harry P. De Koning. (2020) The Drugs of Sleeping Sickness: Their Mechanisms of Action and Resistance, and a Brief History. Tropical Medicine and Infectious Disease 5:1, pages 14.
Crossref
Berthe Amélie Iroungou, Larson Boundenga, Laurette Guignali Mangouka, Berthold Bivigou-Mboumba, Jean Raymond Nzenze & Gael Darren Maganga. (2020) Human African trypanosomiasis in two historical foci of the estuaire province, gabon: A case report. SAGE Open Medical Case Reports 8, pages 2050313X2095989.
Crossref
Ronak G. Gandhi & Ramy H. Elshaboury. 2020. Hunter's Tropical Medicine and Emerging Infectious Diseases. Hunter's Tropical Medicine and Emerging Infectious Diseases 1153 1154 .
Chiara Borsari, María Dolores Jiménez-Antón, Julia Eick, Eugenia Bifeld, Juan José Torrado, Ana Isabel Olías-Molero, María Jesús Corral, Nuno Santarem, Catarina Baptista, Leda Severi, Sheraz Gul, Markus Wolf, Maria Kuzikov, Bernhard Ellinger, Jeanette Reinshagen, Gesa Witt, Pasquale Linciano, Annalisa Tait, Luca Costantino, Rosaria Luciani, Paloma Tejera Nevado, Dorothea Zander-Dinse, Caio H. Franco, Stefania Ferrari, Carolina B. Moraes, Anabela Cordeiro-da-Silva, Glauco Ponterini, Joachim Clos, José María Alunda & Maria Paola Costi. (2019) Discovery of a benzothiophene-flavonol halting miltefosine and antimonial drug resistance in Leishmania parasites through the application of medicinal chemistry, screening and genomics. European Journal of Medicinal Chemistry 183, pages 111676.
Crossref
Philippe MulengaFaustin ChengeMarleen BoelaertAbdon MukalayPascal LutumbaCrispin Lumbala, Oscar LuboyaYves Coppieters. (2019) Integration of Human African Trypanosomiasis Control Activities into Primary Healthcare Services: A Scoping Review. The American Journal of Tropical Medicine and Hygiene 101:5, pages 1114-1125.
Crossref
Stephen Patterson & Alan H. Fairlamb. (2019) Current and Future Prospects of Nitro-compounds as Drugs for Trypanosomiasis and Leishmaniasis. Current Medicinal Chemistry 26:23, pages 4454-4475.
Crossref
Erik de Heuvel, Abhimanyu K. Singh, Ewald Edink, Tiffany van der Meer, Melanie van der Woude, Payman Sadek, Mikkel P. Krell-Jørgensen, Toine van den Bergh, Johan Veerman, Guy Caljon, Titilola D. Kalejaiye, Maikel Wijtmans, Louis Maes, Harry P. de Koning, Geert Jan Sterk, Marco Siderius, Iwan J.P. de Esch, David G. Brown & Rob Leurs. (2019) Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors. Bioorganic & Medicinal Chemistry 27:18, pages 3998-4012.
Crossref
Antonia Efstathiou, Nicolas Gaboriaud-Kolar, Vassilios Myrianthopoulos, Konstantina Vougogiannopoulou, Ines Subota, Stephanie Aicher, Emmanuel Mikros, Philippe Bastin, Alexios-Leandros Skaltsounis, Ketty Soteriadou & Despina Smirlis. (2019) Indirubin Analogues Inhibit Trypanosoma brucei Glycogen Synthase Kinase 3 Short and T. brucei Growth . Antimicrobial Agents and Chemotherapy 63:6.
Crossref
Li-Jun Wang, Hui-Ju Han, Min Zhao, Jian-Wei Liu, Li-Mei Luo, Hong-Ling Wen, Xiang-Rong Qin, Chuan-Min Zhou, Rui Qi, Hao Yu & Xue-Jie Yu. (2019) Trypanosoma dionisii in insectivorous bats from northern China. Acta Tropica 193, pages 124-128.
Crossref
Chiara Borsari, Nuno Santarem, Sara Macedo, María Dolores Jiménez-Antón, Juan J. Torrado, Ana Isabel Olías-Molero, María J. Corral, Annalisa Tait, Stefania Ferrari, Luca Costantino, Rosaria Luciani, Glauco Ponterini, Sheraz Gul, Maria Kuzikov, Bernhard Ellinger, Birte Behrens, Jeanette Reinshagen, José María Alunda, Anabela Cordeiro-da-Silva & Maria Paola Costi. (2019) SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti- Trypanosoma brucei Agent . ACS Medicinal Chemistry Letters 10:4, pages 528-533.
Crossref
Philippe MulengaMarleen BoelaertPascal LutumbaCatiane Vander KelenYves CoppietersFaustin ChengeCrispin Lumbala, Oscar LuboyaAlain Mpanya. (2019) Integration of Human African Trypanosomiasis Control Activities into Primary Health Services in the Democratic Republic of the Congo: A Qualitative Study of Stakeholder Perceptions. The American Journal of Tropical Medicine and Hygiene 100:4, pages 899-906.
Crossref
Nian Chen, Ke Jin, Jingjing Xu, Jianfu Zhang & Yali Weng. (2019) Human African trypanosomiasis caused by Trypanosoma brucei gambiense: The first case report in China. International Journal of Infectious Diseases 79, pages 34-36.
Crossref
Freddie Kansiime, Seraphine Adibaku, Charles Wamboga, Franklin Idi, Charles Drago Kato, Lawrence Yamuah, Michel Vaillant, Deborah Kioy, Piero Olliaro & Enock Matovu. (2018) A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda. Parasites & Vectors 11:1.
Crossref
Federica Ferrigno, Ilaria Biancofiore, Savina Malancona, Simona Ponzi, Giacomo Paonessa, Rita Graziani, Alberto Bresciani, Nadia Gennari, Annalise Di Marco, Marcel Kaiser, Vincenzo Summa, Steven Harper & Jesus M. Ontoria. (2018) Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro. Bioorganic & Medicinal Chemistry Letters 28:23-24, pages 3689-3692.
Crossref
Anthony E. Pegg. (2018) Introduction to the Thematic Minireview Series: Sixty plus years of polyamine research. Journal of Biological Chemistry 293:48, pages 18681-18692.
Crossref
Julien Pedron, Clotilde Boudot, Sandra Bourgeade-Delmas, Alix Sournia-Saquet, Lucie Paloque, Maryam Rastegari, Mansour Abdoulaye, Hussein El-Kashef, Colin Bonduelle, Geneviève Pratviel, Susan Wyllie, Alan H. Fairlamb, Bertrand Courtioux, Pierre Verhaeghe & Alexis Valentin. (2018) Antitrypanosomatid Pharmacomodulation at Position 3 of the 8-Nitroquinolin-2(1 H )-one Scaffold Using Palladium-Catalysed Cross-Coupling Reactions . ChemMedChem 13:20, pages 2217-2228.
Crossref
Catriona H. Baker & Susan C. Welburn. (2018) The Long Wait for a New Drug for Human African Trypanosomiasis. Trends in Parasitology 34:10, pages 818-827.
Crossref
Richard J. WallEva RicoIva LukacFabio ZuccottoSara ElgIan H. GilbertYvonne Freund, M. R. K. Alley, Mark C. FieldSusan WyllieDavid Horn. (2018) Clinical and veterinary trypanocidal benzoxaboroles target CPSF3. Proceedings of the National Academy of Sciences 115:38, pages 9616-9621.
Crossref
Adam J. RobertsJoanne DunnePaul ScullionSuzanne NorvalAlan H. Fairlamb. (2018) A role for trypanosomatid aldo-keto reductases in methylglyoxal, prostaglandin and isoprostane metabolism. Biochemical Journal 475:16, pages 2593-2610.
Crossref
Natalia Tiberti & Jean-Charles Sanchez. (2018) Sleeping Sickness in the ‘Omics Era. PROTEOMICS - Clinical Applications 12:4, pages 1700041.
Crossref
Léon Mbiyangandu Kazumba, Jean-Claude Tshinzobe Kaka, Dieudonné Mumba Ngoyi & Désiré Tshala-Katumbay. (2018) Mortality trends and risk factors in advanced stage-2 Human African Trypanosomiasis: A critical appraisal of 23 years of experience in the Democratic Republic of Congo. PLOS Neglected Tropical Diseases 12:6, pages e0006504.
Crossref
Raoul De Gasparo, Elke Brodbeck‐Persch, Steve Bryson, Nina B. Hentzen, Marcel Kaiser, Emil F. Pai, R. Luise Krauth‐Siegel & François Diederich. (2018) Biological Evaluation and X‐ray Co‐crystal Structures of Cyclohexylpyrrolidine Ligands for Trypanothione Reductase, an Enzyme from the Redox Metabolism of Trypanosoma. ChemMedChem 13:9, pages 957-967.
Crossref
Irene G. Salado, Adrienn Baán, Tomas Verdeyen, An Matheeussen, Guy Caljon, Pieter Van der Veken, Filip Kiekens, Louis Maes & Koen Augustyns. (2018) Optimization of the pharmacokinetic properties of potent anti-trypanosomal triazine derivatives. European Journal of Medicinal Chemistry 151, pages 18-26.
Crossref
Ning Zhang, Martin Zoltner, Ka-Fai Leung, Paul Scullion, Sebastian Hutchinson, Ricardo C. del Pino, Isabel M. Vincent, Yong-Kang Zhang, Yvonne R. Freund, Michael R. K. Alley, Robert T. Jacobs, Kevin D. Read, Michael P. Barrett, David Horn & Mark C. Field. (2018) Host-parasite co-metabolic activation of antitrypanosomal aminomethyl-benzoxaboroles. PLOS Pathogens 14:2, pages e1006850.
Crossref
Nicole LoGiudice, Linh Le, Irene Abuan, Yvette Leizorek & Sigrid Roberts. (2018) Alpha-Difluoromethylornithine, an Irreversible Inhibitor of Polyamine Biosynthesis, as a Therapeutic Strategy against Hyperproliferative and Infectious Diseases. Medical Sciences 6:1, pages 12.
Crossref
C. Calligaris, F. Klapczynski, H.A. Cung, V. Grégoire & A. Améri. (2018) Méningoencéphalite parasitaire : à propos d’un cas de trypanosomiase humaine africaine. Pratique Neurologique - FMC 9:1, pages 48-52.
Crossref
François Chappuis. (2018) Oral fexinidazole for human African trypanosomiasis. The Lancet 391:10116, pages 100-102.
Crossref
Sbaraglini Maria Laura, Bellera Carolina Leticia & Talevi Alan. 2018. The Microbiology of Central Nervous System Infections. The Microbiology of Central Nervous System Infections 279 303 .
Mariame Camara, Eric Ouattara, Alexandre Duvignaud, René Migliani, Oumou Camara, Mamadou Leno, Philippe Solano, Bruno Bucheton, Mamadou Camara & Denis Malvy. (2017) Impact of the Ebola outbreak on Trypanosoma brucei gambiense infection medical activities in coastal Guinea, 2014-2015: A retrospective analysis from the Guinean national Human African Trypanosomiasis control program. PLOS Neglected Tropical Diseases 11:11, pages e0006060.
Crossref
Crispin Lumbala, Paul R. Bessell, Pascal Lutumba, Sylvain Baloji, Sylvain Biéler & Joseph M. Ndung'u. (2017) Performance of the SD BIOLINE® HAT rapid test in various diagnostic algorithms for gambiense human African trypanosomiasis in the Democratic Republic of the Congo. PLOS ONE 12:7, pages e0180555.
Crossref
Louise E. Kerry, Elaine E. Pegg, Donald P. Cameron, James Budzak, Gretchen Poortinga, Katherine M. Hannan, Ross D. Hannan & Gloria Rudenko. (2017) Selective inhibition of RNA polymerase I transcription as a potential approach to treat African trypanosomiasis. PLOS Neglected Tropical Diseases 11:3, pages e0005432.
Crossref
Francisco José Fueyo González, Godwin U. Ebiloma, Carolina Izquierdo García, Victor Bruggeman, José María Sánchez Villamañán, Anne Donachie, Emmanuel Oluwadare Balogun, Daniel Ken Inaoka, Tomoo Shiba, Shigeharu Harada, Kiyoshi Kita, Harry P. de Koning & Christophe Dardonville. (2017) Conjugates of 2,4-Dihydroxybenzoate and Salicylhydroxamate and Lipocations Display Potent Antiparasite Effects by Efficiently Targeting the Trypanosoma brucei and Trypanosoma congolense Mitochondrion . Journal of Medicinal Chemistry 60:4, pages 1509-1522.
Crossref
Kat S. Rock, Steve J. Torr, Crispin Lumbala & Matt J. Keeling. (2017) Predicting the Impact of Intervention Strategies for Sleeping Sickness in Two High-Endemicity Health Zones of the Democratic Republic of Congo. PLOS Neglected Tropical Diseases 11:1, pages e0005162.
Crossref
Michael Berninger, Ines Schmidt, Alicia Ponte-Sucre & Ulrike Holzgrabe. (2017) Novel lead compounds in pre-clinical development against African sleeping sickness. MedChemComm 8:10, pages 1872-1890.
Crossref
Chiara Borsari, Nuno Santarem, Juan Torrado, Ana Isabel Olías, María Jesús Corral, Catarina Baptista, Sheraz Gul, Markus Wolf, Maria Kuzikov, Bernhard Ellinger, Gesa Witt, Philip Gribbon, Jeanette Reinshagen, Pasquale Linciano, Annalisa Tait, Luca Costantino, Lucio H. Freitas-Junior, Carolina B. Moraes, Pascoalino Bruno dos Santos, Laura Maria Alcântara, Caio Haddad Franco, Claudia Danielli Bertolacini, Vanessa Fontana, Paloma Tejera Nevado, Joachim Clos, José María Alunda, Anabela Cordeiro-da-Silva, Stefania Ferrari & Maria Paola Costi. (2017) Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds. European Journal of Medicinal Chemistry 126, pages 1129-1135.
Crossref
Y.-K. Zhang, Y.R. Freund & R.T. Jacobs. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III 516 528 .
FEDERICA GIORDANI, LIAM J. MORRISON, TIM G. ROWAN, HARRY P. DE KONING & MICHAEL P. BARRETT. (2016) The animal trypanosomiases and their chemotherapy: a review. Parasitology 143:14, pages 1862-1889.
Crossref
Verónica Seguel, Lorena Castro, Chantal Reigada, Leonel Cortes, María V. Díaz, Mariana R. Miranda, Claudio A. Pereira, Michel Lapier, Carolina Campos-Estrada, Antonio Morello, Ulrike Kemmerling, Juan D. Maya & Rodrigo López-Muñoz. (2016) Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target. Experimental Parasitology 171, pages 23-32.
Crossref
Aziz Filali-Ansary, Cécile Augé, Audrey Abgrall, Marie Souchaud, Franck Pellissier, Olaf Valverde Mordt, Séverine Blesson & Ger-Jan Sanderink. (2016) A DBS method for quantitation of the new oral trypanocidal drug fexinidazole and its active metabolites. Bioanalysis 8:19, pages 2045-2063.
Crossref
Bryan C. Jensen, Nick Booster, Rama Subba Rao Vidadala, Dustin J. Maly & Marilyn Parsons. (2016) A novel protein kinase is essential in bloodstream Trypanosoma brucei. International Journal for Parasitology 46:8, pages 479-483.
Crossref
S. Jauréguiberry & E. Caumes. (2016) Quand évoquer une cause parasitaire à une infection du système nerveux central ?When should nervous system parasitic infection be raised?. Réanimation 25:S2, pages 69-82.
Crossref
Lynne Shore Garcia. 2016. Diagnostic Medical Parasitology. Diagnostic Medical Parasitology 810 844 .
Angeliki-Sofia Foscolos, Ioannis Papanastasiou, George B. Foscolos, Andrew Tsotinis, Tahsin F. Kellici, Thomas Mavromoustakos, Martin C. Taylor & John M. Kelly. (2016) New hydrazones of 5-nitro-2-furaldehyde with adamantanealkanohydrazides: synthesis and in vitro trypanocidal activity. MedChemComm 7:6, pages 1229-1236.
Crossref
Hamidou Ilboudo, Oumou Camara, Sophie Ravel, Bruno Bucheton, Veerle Lejon, Mamadou Camara, Jacques Kaboré, Vincent Jamonneau & Stijn Deborggraeve. (2015) Trypanosoma brucei gambiense Spliced Leader RNA Is a More Specific Marker for Cure of Human African Trypanosomiasis Than T. b. gambiense DNA: Table 1. . Journal of Infectious Diseases 212:12, pages 1996-1998.
Crossref
Boris Rodenko, Martin J. Wanner, Abdulsalam A. M. Alkhaldi, Godwin U. Ebiloma, Rebecca L. Barnes, Marcel Kaiser, Reto Brun, Richard McCulloch, Gerrit-Jan Koomen & Harry P. de Koning. (2015) Targeting the Parasite's DNA with Methyltriazenyl Purine Analogs Is a Safe, Selective, and Efficacious Antitrypanosomal Strategy. Antimicrobial Agents and Chemotherapy 59:11, pages 6708-6716.
Crossref
Irene Sola, Sílvia Castellà, Elisabet Viayna, Carles Galdeano, Martin C. Taylor, Stephen Y. Gbedema, Belén Pérez, M. Victòria Clos, Deuan C. Jones, Alan H. Fairlamb, Colin W. Wright, John M. Kelly & Diego Muñoz-Torrero. (2015) Synthesis, biological profiling and mechanistic studies of 4-aminoquinoline-based heterodimeric compounds with dual trypanocidal–antiplasmodial activity. Bioorganic & Medicinal Chemistry 23:16, pages 5156-5167.
Crossref
Zhao-Rong LunDe-Hua Lai, Yan-Zi WenLing-Ling ZhengJi-Long ShenTing-Bo YangWen-Liang ZhouLiang-Hu QuGeoff HideFrancisco J. Ayala. (2015) Cancer in the parasitic protozoans Trypanosoma brucei and Toxoplasma gondii . Proceedings of the National Academy of Sciences 112:29, pages 8835-8842.
Crossref
Graeme Bilbe. (2015) Overcoming neglect of kinetoplastid diseases. Science 348:6238, pages 974-976.
Crossref
Ilkay Erdogan Orhan, Nilgun Ozturk & Bilge Sener. (2015) Antiprotozoal assessment and phenolic acid profiling of five Fumaria (fumitory) species. Asian Pacific Journal of Tropical Medicine 8:4, pages 283-286.
Crossref
Vincent Jamonneau, Oumou Camara, Hamidou Ilboudo, Moana Peylhard, Mathurin Koffi, Hassane Sakande, Louis N’Dri, Djénéba Sanou, Emilie Dama, Mamadou Camara & Veerle Lejon. (2015) Accuracy of Individual Rapid Tests for Serodiagnosis of Gambiense Sleeping Sickness in West Africa. PLOS Neglected Tropical Diseases 9:2, pages e0003480.
Crossref
Julien Bonnet, Clotilde Boudot & Bertrand Courtioux. (2015) Overview of the Diagnostic Methods Used in the Field for Human African Trypanosomiasis: What Could Change in the Next Years?. BioMed Research International 2015, pages 1-10.
Crossref